FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2007705125> ?p ?o ?g. }

• W2007705125 abstract "You have accessJournal of UrologyPenis/Testis/Urethra: Benign & Malignant Disease1 Apr 2011599 RANDOMIZED TRIAL COMPARING TWO DOSES POLIDOCANOL FOR SCLEROTHERAPY OF HYDORCELE AND SPERMATOCELE Dag Sandblom, Sten Holmang, and Staffan Jahnsson Dag SandblomDag Sandblom Orebro, Sweden More articles by this author , Sten HolmangSten Holmang Gothenburg, Sweden More articles by this author , and Staffan JahnssonStaffan Jahnsson Linkoping, Sweden More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2011.02.1431AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES Sclerotherapy for hydrocele or spermatocele using Polidocanol combines high efficiency with low morbidity. The optimal dose is not known. To investigate treatment efficacy and morbidity using Polidocanol sclerotherapy 2 ml or 4 ml for hydrocele or spermatocele we performed a study. If the fluid contained sperms we defined it as a spermatocele/epididymal cyst. METHODS A double blind randomized clinical trial using either 2 ml or 4 ml Polidocanol for sclerotherapy of hydrocele or spermatocele was conducted in three university hospitals from 1993–2005 and recruiting 224 evaluable patients. The fluid was evacuated and 2 ml or 4 ml Polidocanol was injected by an assisting nurse with no possibility for anyone else to see the amount injected. Three months later at follow-up morbidity was studied by a questionnaire filled in by the patient. Recurrence of fluid was clinically determined and generally retreated. Complications were also detected through reading the medical records. RESULTS After the first treatment cure was observed in 59% in the 4 ml group and in 47% in the 2 ml group (p=0.04). In the 4 ml group more patients than in the 2 ml group had complications (31% versus 18%, p=0.04). Complications were mostly of low or moderate intensity with no or occasional need for medication. After one to four treatments 210 out of 224 patients (89%) were cured and another 10 patients (5%) were left with small amount of fluid with no difference between the groups.In hydroceles/spermatoceles larger than 175 ml cure after the first treatment was observed in 58% in the 4 ml group and in 34% in the 2 ml group (p=0.012) without differences in complications between the groups. CONCLUSIONS Sclerotherapy using Polidocanol was in the present study an efficient treatment for hydrocele or spermatocele with 94% satisfactory results after one to four treatments. A dose of 4 ml was superior to 2 ml, particularly in celes with larger amount of fluid. Variables of importance for recurrence after first round of sclerotherapy Variable Univariate OR(95% CI) Multivariate OR(95% CI) Time from onset 24 months or less 1,00 1,00 <>24 months 1,79(1,03-3,11) 1,91(1,06-3,47) not known 1,38(0,46-4,12) 1,55(0,60-4,83) Type of cele Spermatocele 1,00 1,00 hydrocele 1,35(0,80-2,29) 1,53(0,88-2,68) Volume of fluid 175 ml or less 1,00 1,00 <>175 ml 1,70(1,00-2,89) 1,66(0,94-2,92) Amount of Polidocanol 2ml 1,0 1,0 4 ml 0,58(0,34-0,99) 0,56(0,32-0,97) © 2011 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 185Issue 4SApril 2011Page: e241-e242 Advertisement Copyright & Permissions© 2011 by American Urological Association Education and Research, Inc.MetricsAuthor Information Dag Sandblom Orebro, Sweden More articles by this author Sten Holmang Gothenburg, Sweden More articles by this author Staffan Jahnsson Linkoping, Sweden More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ..." @default.
• W2007705125 created "2016-06-24" @default.
• W2007705125 creator A5028143557 @default.
• W2007705125 creator A5067397242 @default.
• W2007705125 creator A5069584602 @default.
• W2007705125 date "2011-04-01" @default.
• W2007705125 modified "2023-09-25" @default.
• W2007705125 title "599 RANDOMIZED TRIAL COMPARING TWO DOSES POLIDOCANOL FOR SCLEROTHERAPY OF HYDORCELE AND SPERMATOCELE" @default.
• W2007705125 doi "https://doi.org/10.1016/j.juro.2011.02.1431" @default.
• W2007705125 hasPublicationYear "2011" @default.
• W2007705125 type Work @default.
• W2007705125 sameAs 2007705125 @default.
• W2007705125 citedByCount "0" @default.
• W2007705125 crossrefType "journal-article" @default.
• W2007705125 hasAuthorship W2007705125A5028143557 @default.
• W2007705125 hasAuthorship W2007705125A5067397242 @default.
• W2007705125 hasAuthorship W2007705125A5069584602 @default.
• W2007705125 hasConcept C141071460 @default.
• W2007705125 hasConcept C168563851 @default.
• W2007705125 hasConcept C2777143589 @default.
• W2007705125 hasConcept C2778230777 @default.
• W2007705125 hasConcept C2780950165 @default.
• W2007705125 hasConcept C71924100 @default.
• W2007705125 hasConceptScore W2007705125C141071460 @default.
• W2007705125 hasConceptScore W2007705125C168563851 @default.
• W2007705125 hasConceptScore W2007705125C2777143589 @default.
• W2007705125 hasConceptScore W2007705125C2778230777 @default.
• W2007705125 hasConceptScore W2007705125C2780950165 @default.
• W2007705125 hasConceptScore W2007705125C71924100 @default.
• W2007705125 hasIssue "4S" @default.
• W2007705125 hasLocation W20077051251 @default.
• W2007705125 hasOpenAccess W2007705125 @default.
• W2007705125 hasPrimaryLocation W20077051251 @default.
• W2007705125 hasRelatedWork W161305747 @default.
• W2007705125 hasRelatedWork W2007553271 @default.
• W2007705125 hasRelatedWork W2010164712 @default.
• W2007705125 hasRelatedWork W2027685663 @default.
• W2007705125 hasRelatedWork W2114092941 @default.
• W2007705125 hasRelatedWork W2290804085 @default.
• W2007705125 hasRelatedWork W2334496732 @default.
• W2007705125 hasRelatedWork W2397294672 @default.
• W2007705125 hasRelatedWork W2781990019 @default.
• W2007705125 hasRelatedWork W2896558888 @default.
• W2007705125 hasVolume "185" @default.
• W2007705125 isParatext "false" @default.
• W2007705125 isRetracted "false" @default.
• W2007705125 magId "2007705125" @default.
• W2007705125 workType "article" @default.